| abstract |
The present invention describes a novel gene expression system. The system is based on the use of the derived sequence of the first intron of the tyrosine hydroxylase gene, in particular with transcription enhancing properties. The system is particularly useful for the production of proteins in vitro, ex vivo or in vivo, especially in gene therapy applications. |